Characterization and sensitivity to antibiotics of bacteria isolated from the lower respiratory tract of ventilated patients hospitalized in intensive care units

Brazilian Journal of Infectious Diseases

Volumn 16, Issue 1, 2012, Pages 45-51

  Medell, Manuel ^a   Medell, Mariana ^a   Martínez, Alicia ^b   Valdés, Rodolfo ^c  

^a HOSPITAL CLINICOQUIRÚRGICO HERMANOS AMEIJEIRAS   (Cuba)

^b Juan Manuel Marquez Pediatric Hospital   (Cuba)

^c CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

Anti bacterial agents; Bronchopneumonia; Respiratory care units

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZLOCILLIN; AZTREONAM; CEFOXITIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULFAMETHOXAZOLE; SULTAMICILLIN; TIMENTIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CULTURE TECHNIQUE; HOSPITAL INFECTION; HOSPITAL LABORATORY; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; OBSERVATIONAL STUDY; PREVALENCE; PSEUDOMONAS; QUANTITATIVE ASSAY; TIME SERIES ANALYSIS; TREND STUDY;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DISK DIFFUSION ANTIMICROBIAL TESTS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INTENSIVE CARE UNITS; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 84856562118     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(12)70273-8     Document Type: Article

References (29)

1. Majno G. The ancient riddle of σñψις (sepsis). J Infect Dis 1991, 163:937-945.
2. Slaughter S., Hayden M.K., Nathan C., et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant Enterococci in a medical intensive care unit. Ann Intern Med 1996, 125:448-456.
3. Boye C.S., Sow A.I. Nosocomial infections: main causative agents. Reported as causal agents of nosocomial infections. Dakar Med 2007, 52:77-81.
4. Haley R.W., Culver D.H., White J.W., et al. The nationwide nosocomial infection rate: a new need for vital statistics. Am J Epidemiol 1985, 121:159-167.
5. Boucher H.W., Talbot G.H., Bradley J.S., et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1-12.
6. Weinstein R.A. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med 1991, 91:179-184.
7. Hiramatsu K., Aritaka N., Hanaki H., et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997, 350:1670-1673.
8. Stone P.W., Hedblom E.C., Murphy D.M., et al. The economic impact of infection control: making the business case for increased infection control resources. Am J Infect Control 2005, 33:542-547.
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobic disc susceptibility test. Approved standard M2-A2S2. 1981. National Committee for Clinical Laboratory Standards. Wayne Pa. EEUU.
10. Anton Y.P., David C.H. Hospital-acquired infections due to Gram-negative bacteria. N Engl J Med 2010, 362:1804-1813.
11. Wunderink R.G. Attributable mortality of ventilator-associated pneumonia. Sepsis 1998, 1:211-221.
12. Tadié J.M., Trinquart L., Jannière-Nartey C., et al. Prediction of nosocomial infection acquisition in ventilated patients by nasal nitric oxide: Proof-of-Concept Study. Shock 2010, 34:217-221.
13. Chopra I., Schofield C., Everett M., et al. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. Lancet Infect Dis 2008, 8:133-139.
14. Klevens R.M., Edwards J.R., Richards C.L., et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007, 122:160-166.
15. Daniels T.L., Deppen S., Arbogast P.G., et al. Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care units. Infect Control Hosp Epidemiol 2008, 11:1080-1083.
16. Haverkorn M.L., Michel M.F. Nosocomial klebsiellas. I. Colonization of hospitalized patients. J Hyg 1979, 82:177-193.
17. Malini A., Deepa E.K., Gokul B.N., et al. Non-fermenting gram-negative bacilli infections in a tertiary care hospital in Kolar, Karnataka. J Lab Physicians 2009, 1:62-66.
18. Diomedi A. Infecciones por Acinetobacter baumannii pan-resistente. Consideraciones epidemiológicas y de manejo antimicrobiano actualizado. Rev Chil Infect 2008, 22:298-320.
19. Espinosa F., Hart M., Halley M.C., et al. Bacterial resistance of isolated strains at " Hermanos Ameijeiras" Hospital. Rev Cubana Med 2008, 47:1-8.
20. Falagas M.E., Grammatikos A.P., Michalopoulos A. Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev Anti Infect Ther 2008, 6:593-600.
21. Kumarasamy K.K., Mark A., Toleman M.A., et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010, 10:597-602.
22. Reis A.O., Luz D., Tognim M., et al. Polymyxin resistant Acinetobacter spp. isolates: what is next?. Emerg Infect Dis 2003, 9:50-51.
23. Park Y.K., Peck K.R., Cheong H.S., et al. Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea. Emerg Infect Dis 2009, 15:107-109.
24. Adams M.D., Nickel G.C., Bajaksouzian S., et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 2009, 53:3628-3634.
25. Seligman S.J. Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram- negative bacteria. Antimicrob Ag Chemother 1978, 13:70-73.
26. Rong-Dih L., Po-Ren H., Shan-Chwen C.H., et al. Bacteremia due to Klebsiella oxytoca: clinical features of patients and antimicrobial susceptibilities of the isolates. Clin Infect Dis 1997, 24:1217-1222.
27. Tomas J.M., Benedi V.J., Ciurana B., et al. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infect Immun 1986, 54:85-89.
28. Podschun R., Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998, 11:589-603.
29. Yang Y., Rasmussen B.A., Shlaes D.M., Class A beta-lactamases-enzyme-inhibitor interactions and resistance. Pharmacol Ther 1999, 83:141-151.